BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29479355)

  • 1. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
    Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
    Front Immunol; 2018; 9():203. PubMed ID: 29479355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Pathogenic Variant in
    Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
    Front Immunol; 2020; 11():884. PubMed ID: 32625199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human immunodeficiency syndrome caused by mutations in CARMIL2.
    Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
    Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations.
    Maccari ME; Speckmann C; Heeg M; Reimer A; Casetti F; Has C; Ehl S; Castro CN
    Clin Immunol; 2019 Nov; 208():108228. PubMed ID: 31195081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
    Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
    Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
    Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
    Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
    J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
    Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
    Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers.
    Marangi G; Garcovich S; Sante GD; Orteschi D; Frangella S; Scaldaferri F; Genuardi M; Peris K; Gurrieri F; Zollino M
    Acta Derm Venereol; 2020 Jan; 100(1):adv00038. PubMed ID: 31709449
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation.
    Moshous D; Martin E; Carpentier W; Lim A; Callebaut I; Canioni D; Hauck F; Majewski J; Schwartzentruber J; Nitschke P; Sirvent N; Frange P; Picard C; Blanche S; Revy P; Fischer A; Latour S; Jabado N; de Villartay JP
    J Allergy Clin Immunol; 2013 Jun; 131(6):1594-603. PubMed ID: 23522482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy.
    Zhu Y; Ye L; Huang H; Xu X; Liu Y; Wang J; Jin Y
    Front Pediatr; 2022; 10():1042302. PubMed ID: 36727012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel CARMIL2 Mutation Resulting in Combined Immunodeficiency Manifesting with Dermatitis, Fungal, and Viral Skin Infections As Well as Selective Antibody Deficiency.
    Atschekzei F; Jacobs R; Wetzke M; Sogkas G; Schröder C; Ahrenstorf G; Dhingra A; Ott H; Baumann U; Schmidt RE
    J Clin Immunol; 2019 Apr; 39(3):274-276. PubMed ID: 31001706
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire.
    Frizinsky S; Rechavi E; Barel O; Najeeb RH; Greenberger S; Lee YN; Simon AJ; Lev A; Ma CA; Sun G; Blackstone SA; Milner JD; Somech R; Stauber T
    J Clin Immunol; 2019 May; 39(4):401-413. PubMed ID: 31037583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential founder variant in
    Sorte HS; Osnes LT; Fevang B; Aukrust P; Erichsen HC; Backe PH; Abrahamsen TG; Kittang OB; Øverland T; Jhangiani SN; Muzny DM; Vigeland MD; Samarakoon P; Gambin T; Akdemir ZH; Gibbs RA; Rødningen OK; Lyle R; Lupski JR; Stray-Pedersen A
    Mol Genet Genomic Med; 2016 Nov; 4(6):604-616. PubMed ID: 27896283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
    Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Generalized verrucosis and abnormal T cell activation due to homozygous TAOK2 mutation.
    Molho-Pessach V; Ramot Y; Mogilevsky M; Cohen-Daniel L; Eisenstein EM; Abu-Libdeh A; Siam I; Berger M; Karni R; Zlotogorski A
    J Dermatol Sci; 2017 Aug; 87(2):123-129. PubMed ID: 28385331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
    Wang Y; Ma CS; Ling Y; Bousfiha A; Camcioglu Y; Jacquot S; Payne K; Crestani E; Roncagalli R; Belkadi A; Kerner G; Lorenzo L; Deswarte C; Chrabieh M; Patin E; Vincent QB; Müller-Fleckenstein I; Fleckenstein B; Ailal F; Quintana-Murci L; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Puel A; Bustamante J; Boisson-Dupuis S; Malissen M; Malissen B; Abel L; Hovnanian A; Notarangelo LD; Jouanguy E; Tangye SG; Béziat V; Casanova JL
    J Exp Med; 2016 Oct; 213(11):2413-2435. PubMed ID: 27647349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
    Lévy R; Gothe F; Momenilandi M; Magg T; Materna M; Peters P; Raedler J; Philippot Q; Rack-Hoch AL; Langlais D; Bourgey M; Lanz AL; Ogishi M; Rosain J; Martin E; Latour S; Vladikine N; Distefano M; Khan T; Rapaport F; Schulz MS; Holzer U; Fasth A; Sogkas G; Speckmann C; Troilo A; Bigley V; Roppelt A; Dinur-Schejter Y; Toker O; Bronken Martinsen KH; Sherkat R; Somekh I; Somech R; Shouval DS; Kühl JS; Ip W; McDermott EM; Cliffe L; Ozen A; Baris S; Rangarajan HG; Jouanguy E; Puel A; Bustamante J; Alyanakian MA; Fusaro M; Wang Y; Kong XF; Cobat A; Boutboul D; Castelle M; Aguilar C; Hermine O; Cheminant M; Suarez F; Yildiran A; Bousfiha A; Al-Mousa H; Alsohime F; Cagdas D; Abraham RS; Knutsen AP; Fevang B; Bhattad S; Kiykim A; Erman B; Arikoglu T; Unal E; Kumar A; Geier CB; Baumann U; Neven B; ; Rohlfs M; Walz C; Abel L; Malissen B; Marr N; Klein C; Casanova JL; Hauck F; Béziat V
    J Exp Med; 2023 Feb; 220(2):. PubMed ID: 36515678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene.
    Lagresle-Peyrou C; Luce S; Ouchani F; Soheili TS; Sadek H; Chouteau M; Durand A; Pic I; Majewski J; Brouzes C; Lambert N; Bohineust A; Verhoeyen E; Cosset FL; Magerus-Chatinet A; Rieux-Laucat F; Gandemer V; Monnier D; Heijmans C; van Gijn M; Dalm VA; Mahlaoui N; Stephan JL; Picard C; Durandy A; Kracker S; Hivroz C; Jabado N; de Saint Basile G; Fischer A; Cavazzana M; André-Schmutz I
    J Allergy Clin Immunol; 2016 Dec; 138(6):1681-1689.e8. PubMed ID: 27405666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.
    Chen R; Giliani S; Lanzi G; Mias GI; Lonardi S; Dobbs K; Manis J; Im H; Gallagher JE; Phanstiel DH; Euskirchen G; Lacroute P; Bettinger K; Moratto D; Weinacht K; Montin D; Gallo E; Mangili G; Porta F; Notarangelo LD; Pedretti S; Al-Herz W; Alfahdli W; Comeau AM; Traister RS; Pai SY; Carella G; Facchetti F; Nadeau KC; Snyder M; Notarangelo LD
    J Allergy Clin Immunol; 2013 Sep; 132(3):656-664.e17. PubMed ID: 23830146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.